Navigation Links
Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing,Promising Antitumor Activity in Multiple Myeloma at ASCO

e support of the myeloma physician and patient communities for the advancement of tanespimycin and look forward to the start of our TIME program."

Tanespimycin Phase 1b Trial Results

The objective of the Phase 1b dose-escalating trial was to define a Phase 2/3 dose of tanespimycin in combination with bortezomib in patients with relapsed, refractory multiple myeloma, as well as to assess pharmacokinetic and pharmacodynamic parameters. Dose escalations in the trial ranged from 100- 340 mg/m2 for tanespimycin, and from 0.7-1.3 mg/m2 for bortezomib. Patients received tanespimycin via 1-hour infusion following the bortezomib dose 2 times per week every 2 weeks out of 3 weeks.

Data on 56 patients enrolled in 7 dose cohorts (100-340 mg/m2 of tanespimycin; 0.7-1.3 mg/m2 of bortezomib) were reported. Of the 28 patients enrolled in cohort 7 (340 mg/m2 tanespimycin, 1.3 mg/m2 bortezomib), 19 received the Cremophor formulation of tanespimycin and 9 patients received the new injectable suspension formulation of tanespimycin.

Of these 56 patients, all had received multiple prior chemotherapy regimens (median of 4), and 67% had received bone marrow transplants.

Responses were observed across dose cohorts in bortezomib-naove, pretreated and refractory patients (refractory is defined as having no response to prior bortezomib or having progressed on or within 60 days of their last dose of a bortezomib-containing regimen). Response rate in multiple myeloma is measured primarily by the level of myeloma (M) protein in the patient's bone marrow. In those patients who received a dose of 1.0 or 1.3 mg/m2 of bortezomib, the overall response rate including complete, partial and minimal responses was 44% (18 out of 41 patients evaluable for response):

    -- 8 out of 14 bortezomib-naive patients (57%);

    -- 7 out of 16 bortezomib-pretreated patients (44%); and

    -- 3 out of 11 bortezomib-refractory patients (27%).



    In the bortezomib-ref
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90 Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory Breast and Ovarian Cancers at ASCO
2. Kosan Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Epothilone KOS-1584 at ASCO
3. Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO
4. Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR
5. Kosan Presents Preclinical Antitumor and Safety Data On Next-Generation Epothilone KOS-1803 at AACR
6. Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor Tanespimycin (KOS-953) at AACR
7. Kosan Announces Data Presentations at Upcoming AACR Annual Meeting
8. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
9. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
10. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
11. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
Post Your Comments:
(Date:4/21/2015)... , April 21, 2015 The non-invasive & minimally invasive cardiac output monitoring ... 2019. Geographically, Europe is segmented as Germany ... France and Rest of Europe (RoE). ... non-invasive & minimally invasive cardiac output monitoring devices market around 35.2% in 2014 followed ... Netherlands , Sweden , Poland ...
(Date:4/21/2015)... England , April 21, 2015 ... Queen,s Award for Enterprise, having more than doubled its ... Oxford PharmaGenesis today celebrates winning the Queen,s Award ... local employer is the world,s first HealthScience Communications consultancy, ... in areas of patient need. Having more than doubled ...
(Date:4/21/2015)... According to a new ... Cell, Blood, Gene Therapy), Product (Instruments, Services, Kits, ... Residual Contamination, Adventitious Agents) - Global Forecast to ... Testing Market was valued at $1,758.69 Million in ... a CAGR of 12.23% to reach $3,130.85 Million ...
Breaking Medicine Technology:European Non-invasive and Minimally Invasive Cardiac Output Monitoring Devices Market by Type, by End-User - Forecast to 2019 2European Non-invasive and Minimally Invasive Cardiac Output Monitoring Devices Market by Type, by End-User - Forecast to 2019 3Queen's Award Crowns Achievements of Local Consultancy 2Queen's Award Crowns Achievements of Local Consultancy 3Queen's Award Crowns Achievements of Local Consultancy 4Queen's Award Crowns Achievements of Local Consultancy 5Biologics Safety Testing Market Worth $3,130.85 Million by 2019 2Biologics Safety Testing Market Worth $3,130.85 Million by 2019 3Biologics Safety Testing Market Worth $3,130.85 Million by 2019 4
... YORK, Dec. 15, 2011  New York University and the ... they have appointed Theodore (Ted) Rappaport, 51, to lead ... Rappaport, currently the William and Bettye ... at Austin (UTA), is a leading educator and entrepreneur ...
... 15, 2011  Today, the Consumer Healthcare Products Association (CHPA), announced ... Five Moms campaign to raise awareness of ... of two teenage boys and a high school math teacher ... the dangers of substance abuse. Millions of ...
Cached Medicine Technology:Wireless Engineering Pioneer Joins NYU-Poly and NYU 2Wireless Engineering Pioneer Joins NYU-Poly and NYU 3Wireless Engineering Pioneer Joins NYU-Poly and NYU 4CHPA's Five Moms Campaign to Stop Medicine Abuse Welcomes New Mom Tammy Walsh 2CHPA's Five Moms Campaign to Stop Medicine Abuse Welcomes New Mom Tammy Walsh 3
(Date:4/21/2015)... WA (PRWEB) April 21, 2015 ... Practice Edition 2 for otolaryngologists, bringing the most ... the healthcare community. Otolaryngologists can now experience ... by a trusted source in the industry, Lyft, ... integration with leading EHRs. , “Lyft is very ...
(Date:4/21/2015)... 2015 QuickMedical, a veteran-owned leader ... now represents Schiller America's line of ... Tests, and Vital Signs Monitors, among many other ... a global leader in the development and production ... in close cooperation with the world's leading physicians ...
(Date:4/21/2015)... April 21, 2015 On April 8th, ... EcoLuxe Lounge at the world famous Avalon Hollywood. Organized ... product placement in TV and film, the EcoLuxe Lounge ... at many awards ceremonies and festivals throughout the year. ... of eco-friendly and socially conscious products and services, this ...
(Date:4/21/2015)... The 2015 Market Research Report on ... and in-depth study on the current state of ... a focus on the Chinese situation. , ... research are Cargill, Fbc Industries, Posy Pharmachem, Fuso, ... Lianyungang Mupro Fi, Yixing-Union, Debang Fine Chemical, Shuren ...
(Date:4/21/2015)... This year, in recognition of IAM, the Foundation ... publish a unique awareness campaign featuring real-life patients, affected ... of May and carry the message, "Be Inspired. Use ... was chosen to encourage the general public to learn ... support our mission of educating, inspiring and connecting all ...
Breaking Medicine News(10 mins):Health News:Lyft Expands Its Offerings to Include Dragon® Medical Practice Edition 2 for Otolaryngologists. 2Health News:QuickMedical Launches New Product Line: Schiller America 2Health News:QuickMedical Launches New Product Line: Schiller America 3Health News:Hollywood's Santana Dempsey and Choices Recovery South Bend Examine Victory over Personal Struggles 2Health News:Sodium Citrate Industry Global Key Manufacturers Analysis Report 2015-2020 2Health News:Sodium Citrate Industry Global Key Manufacturers Analysis Report 2015-2020 3Health News:May is Ichthyosis Awareness Month. Use Your Voice. 2
... LLC announces the pending release of its newest report, ... As a result of the March 9, 2009 reversal ... stem cell research, suppliers of stem cell related products are ... in the stem cell products market. In this report, BioInformatics, ...
... State University, discusses new research exploring weight discrimination against women in the workplace. , ... more information. , , , ... , , , , ... , , , , ...
... April 7 Did you know that April 16th is National Stress ... due? I don,t know, but spas can help. ISPA,s research shows ... relax and relieve or reduce stress. Here are some other facts ... 1/3 of Americans are living with extreme stress and nearly half ...
... Struggling with infertility issues on top of dealing with ... The troubled economy has slowed down, but biological clocks ... and men have biological clock realities. So, for ... they need some physical and financial help, there,s a ...
... Economic ActivitySACRAMENTO, Calif., April 7 California health plans ... economy, generating 130,000 jobs and $13.5 billion in economic ... by the California Association of Health Plans ... an outside consulting firm with expertise in health care ...
... Physicians for Human Rights responds to the publication of a ... that health professionals who participated in interrogations in CIA secret detention ... participated in torture. , ... Cambridge, MA (Vocus) April ...
Cached Medicine News:Health News:BioInformatics, LLC New Report - Capitalizing on New Opportunities for Stem Cell Products 2Health News:BioInformatics, LLC New Report - Capitalizing on New Opportunities for Stem Cell Products 3Health News:Weight discrimination could contribute to the glass ceiling effect for women, study finds 2Health News:Weight discrimination could contribute to the glass ceiling effect for women, study finds 3Health News:Weight discrimination could contribute to the glass ceiling effect for women, study finds 4Health News:Spas Add Years to Your Life 2Health News:Infertility Issues and No Insurance Do Not Necessarily Mean No Hope for Baby 2Health News:California Health Plans Vital to State's Economy 2Health News:In Wake of ICRC Report, Health Professionals Must Be Held Accountable for Torture 2Health News:In Wake of ICRC Report, Health Professionals Must Be Held Accountable for Torture 3
Measles IgM ELISA test is an enzyme linked immunosorbent assay (ELISA) for the detection of IgG class antibodies to Measles (Rubeola) in human serum or plasma....
Measles IgM ELISA test is an enzyme linked immunosorbent assay (ELISA) for the detection of IgG class antibodies to Measles (Rubeola) in human serum or plasma....
... Digisonics has set the standard in ... review station, the only fully integrated ... multi-modality reporting., ,DigiView cardiology solutions bring ... professional reporting choices, an integrated clinical ...
... The menu-driven Vapro osmometer determines osmolality ... natural equilibrium. ,What you don't get are ... particles, or other conditions that interfere with ... percent in the clinical range) Vapro osmometer ...
Medicine Products: